Toll-Interacting Protein May Affect Doxorubicin Resistance in Hepatocellular Carcinoma Cell Lines

The NIH Gene Expression Omnibus and Oncomine datasets were analyzed for HCC cell lines with relatively low and high toll-interacting protein expression, and SNU449 and Hep3B cell lines were chosen, respectively.